Search
Acetylcysteine
go.drugbank.com/drugs/DB06151ApprovedInvestigational[A228158,A228163,A228168] Acetylcysteine was granted FDA approval on 14 September 1963.[L31488] … Acetylcysteine is an antioxidant and glutathione inducer indicated for mucolytic therapy and the treatment of [acetaminophen] overdose.
Mixtures: AMINOPLASMAL-10% E INFUSION, AMINOPLASMAL-5% E INFUSIONCategories: Compounds used in a research, industrial, or household settingLamivudine
go.drugbank.com/drugs/DB00709ApprovedInvestigationalIt is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV). … A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring.
Mixtures: TRIUMEQ® 50 MG / 600 MG / 300 MG, TRIUMEQ 50 MG/600 MG/300 MG FILM KAPLI TABLET,90 FILM KAPLI TABLETCategories: Antivirals used in combination for the treatment of HIV infectionsOxolamine
go.drugbank.com/drugs/DB13216ApprovedOxolamine is not approved in the USA, it may be marketed elsewhere internationally as a cough suppressant [L5416]. It is listed as a prescription drug in New Zealand legislation [L5419]. … Oxolamine is also approved in Taiwan for the treatment of respiratory tract inflamation [L5422].
Mixtures: KATARIN 120 MG+50 MG+1 MG/5 ML PEDIATRIK SURUP 100 ML, KATARİN 250 MG/100 MG/2 MG KAPSÜL, 15 ADETProducts: OXOTUSS ŞURUP 50 MG/5 ML, 120 ML, Oksalamin 50 mg/5 ml Şurup, 120 MLMetoprolol
go.drugbank.com/drugs/DB00264ApprovedInvestigational[T274] To this date, it is one of the preferred beta-blockers in general clinical guidelines and it is widely prescribed in the Netherlands, New Zealand, and the US. … [A175162] Metoprolol was developed since 1969 by US Pharmaceutical Holdings I and FDA approved in 1978.[L5527]
Mixtures: Metoprolol Tartrate and Hydrochlorothiazide 100 mg-50 mg, Metoprolol Tartrate and Hydrochlorothiazide 100 mg-25 mgCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesPPI-1040
go.drugbank.com/drugs/DB17620ExperimentalSynonyms: 1-(((z)-hexadec-1-en-1-yl)oxy)-3-((2-oxido-1,3,2-oxazaphospholidin-2-yl)oxy)propan-2-yl (4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoate, 4,7,10,13,16,19-docosahexaenoic acid, 2-((1z)-1-hexadecen-1-yloxy)-1-(((2-oxido-1,3,2-oxazaphospholidin-2-yl)oxy)methyl)ethyl ester, (4z,7z,10z,13z,16z,19z)-Mannitol
go.drugbank.com/drugs/DB00742ApprovedInvestigationalOn October 30, 2020, mannitol was approved by the FDA as add-on maintenance therapy for the control of pulmonary symptoms associated with cystic fibrosis in adult patients and is currently marketed for … Mannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables.
Synonyms: (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexaol, (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexolMixtures: OSMOFUNDIN INJECTION 20%, Sag-MGuaifenesin
go.drugbank.com/drugs/DB00874ApprovedInvestigationalVet approvedAlthough it is principally believed that guaifenesin elicits an action to facilitate productive cough to manage chest congestion [A177661, L6100, F4516, F4522, F4525], it is not known whether the agent … After the negotiation between FDA and major manufacturers, a voluntary transition of labels for not using guaifenesin in children under the age of 4 years was endorsed by FDA in 2008 [F4525].
Mixtures: BROKSIN 6.66 MG/5 ML+100 MG/5 ML SURUP, 150 ML, SUDAFED EKSPEKTORAN 30 MG+100 MG/5 ML ŞURUP, 150 MLInternational brands: Duratuss GRanitidine
go.drugbank.com/drugs/DB00863ApprovedWithdrawn[L10818,F4253] The prevalence of GERD is thought to be 10-20% in western countries. … [A176843] Ranitidine has proven to be an effective treatment for relieving uncomfortable symptoms of gastric acid associated conditions and is therefore widely used in GERD and other gastric-acid related
Categories: MATE 2 Inhibitors, Cytochrome P-450 SubstratesProducts: RANITIDINA 50 MG EN SODIO CLORURO 0.7% POR 100 ML (INFUSION), RANITIDINA 50MG EN SODIO CLORURO 0.7 % POR 50 ML INFUSIONFenofibrate
go.drugbank.com/drugs/DB01039ApprovedInvestigational[L8588,L8591] Fenofibrate was granted FDA approval on 31 December 1993.[L8585]
Mixtures: STAFEN 135/10 MG CAPSULAS, STAFEN 135/10 MG CAPSULASCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2A6 InhibitorsLosartan
go.drugbank.com/drugs/DB00678ApprovedInvestigational[L7423] Losartan was granted FDA approval on 14 April 1995.[L7423] … Losartan is an angiotensin II receptor blocker (ARB) used to treat hypertension.
Synonyms: 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole, (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanolMixtures: EKLIPS FORT 100/25 MG FILM TABLET, TABLET, 90 ADET, Fortzaar 100 mg/25 mg Filmtabletten